The Serologic Response to Cryptosporidium in HIV-Infected Persons: Implications for Epidemiologic Research

Joseph N.S. Eisenberg*

, Jeffrey W. Priest†, Patrick J. Lammie†, and John M. Colford*

Author affiliations: *University of California, Berkeley, California, USA;; †Centers for Disease Control and Prevention, Atlanta, Georgia, USA

Main Article

Table 1

Summary of antibody responses for the 11 cases and their respective controls

	Cases	Controls	Cases	Controls	Cases	Controls	Cases	Controls

Mean	2,784^c	414	2,117^c	-17	1,594	85	1,531	5
Max	12,224	973	11,247	157	9,264	217	9,239	69
Min	102	178	-866	-144	36	41	-5	47
Median	1,334^d	329	433^d	-32	140	56	71^d	1
S.D.	3,560	237	3,531	84	2,880	53	2,884	36
N	11	22	11	22	11	22	11	22

^aIgG response after the date of clinical cryptosporidiosis diagnosis.
^bDifference in IgG response between a sample taken before and after date of cryptosporidiosis diagnosis.
^cCase value is significantly different from control value (p<0.05).
^dCase value is significantly different from control value (p<0.01).
IgG = immunoglobulin G; TX17 = Triton antigen; SD = standard deviation.

Main Article

The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.

File Formats Help:

How do I view different file formats (PDF, DOC, PPT, MPEG) on this site?

Page created: December 09, 2010
Page last updated: December 09, 2010
Page last reviewed: December 09, 2010
Centers for Disease Control and Prevention,
National Center for Emerging and Zoonotic Infectious Diseases (NCEZID)
Office of the Director (OD)

Ahead Of Print

Past Issues

Related Information

Additional Resources

Volume 7, Number 6—December 2001

Research